Pallin, DJ, et al.
Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus
. Annals of Emergency Medicine
2008; 51: 291–298.
Ray, GT, Suaya, JA, Baxter, R. Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S.
population: a retrospective population-based study. BMC Infectious Diseases
2013; 13: 252.
Sattler, CA, Mason, EO Jr., Kaplan, SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatric Infectious Disease Journal
2002; 21: 910–917.
Skiest, DJ, et al.
Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients. Journal of Infection
2007; 54: 427–434.
Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus among players on a high school football team – New York City, 2007. Morbidity Mortality Weekly Report
2009; 58: 52–55.
Popovich, KJ, et al.
Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics. Clinical Infectious Diseases
2010; 50: 979–987.
Miller, LG, et al.
Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation. Clinical Infectious Diseases
2007; 44: 471–482.
Forcade, NA, et al.
Prevalence, severity, and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections in 10 medical clinics in Texas: a South Texas Ambulatory Research Network (STARNet) study. Journal of the American Board of Family Medicine
2011; 24: 543–550.
Labreche, MJ, et al.
Treatment failure and costs in patients with methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections: a South Texas Ambulatory Research Network (STARNet) study. Journal of the American Board of Family Medicine
2013; 26: 508–517.
Kaye, KS, et al.
The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance. Infection Control and Hospital Epidemiology
2005; 26: 346–351.
Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. M100-S24. Wayne, PA: Clinical and Laboratory Standards Institute, 2014.
Rubino, CM, et al.
Oritavancin population pharmacokinetics in healthy subjects and patients with complicated skin and skin structure infections or bacteremia. Antimicrobial Agents and Chemotherapy
2009; 53: 4422–4428.
Falagas, ME, Karageorgopoulos, DE. Adjustment of dosing of antimicrobial agents for bodyweight in adults. Lancet
2010; 375: 248–251.
Hersh, AL, et al.
National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Archives of Internal Medicine
2008; 168: 1585–1591.
Khawcharoenporn, T, et al.
Risk factors for community-associated methicillin-resistant Staphylococcus aureus cellulitis – and the value of recognition. Journal of Hawaii Medicine
2010; 69: 232–236.
Diep, BA, et al.
The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus
. Journal of Infectious Diseases
2008; 197: 1523–1530.
Planet, PJ, et al.
Emergence of the epidemic methicillin-resistant Staphylococcus aureus strain USA300 coincides with horizontal transfer of the arginine catabolic mobile element and speG-mediated adaptations for survival on skin. MBio
2013; 4: e00889–13.
Early, GJ, Seifried, SE. Risk factors for community-associated Staphylococcus aureus skin infection in children of Maui. Hawaii Journal of Medicine and Public Health
2012; 71: 218–223.
Yosipovitch, G, DeVore, A, Dawn, A. Obesity and the skin: skin physiology and skin manifestations of obesity. Journal of American Academy of Dermatology
2007; 56: 901–916; quiz 17–20.
Kupfer, M, et al.
MRSA in a large German university hospital: male gender is a significant risk factor for MRSA acquisition. GMS Krankenhhyg Interdisziplinar
2010; 5: Doc11.
Casey, JA, et al.
A population-based study of the epidemiology and clinical features of methicillin-resistant Staphylococcus aureus infection in Pennsylvania, 2001–2010. Epidemiology and Infection
2013; 141: 1166–1179.
Klevens, RM, et al.
Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Journal of the American Medical Association
2007; 298: 1763–1771.
Laupland, KB, Ross, T, Gregson, DB.
Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000–2006. Journal of Infectious Diseases
2008; 198: 336–343.
Graham, PL 3rd, Lin, SX, Larson, EL. A U.S. population-based survey of Staphylococcus aureus colonization. Annals of Internal Medicine
2006; 144: 318–325.
Delorenze, GN, et al.
Trends in annual incidence of methicillin-resistant Staphylococcus aureus (MRSA) infection in HIV-infected and HIV-uninfected patients. Epidemiology and Infection
2013; 141: 2392–2402.
Landrum, ML, et al.
Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005–2010. Journal of the American Medical Association
2012; 308: 50–59.